Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational study

The Lancet Infectious Diseases 2026

View at publisher
Authors: Josefina Lorena Razzini, Iago Giné-Vázquez, Jing Jin, María-Isolina Santiago-Pérez, Olaia Pérez-Martínez, María-Teresa Otero-Barrós, Nuria Suárez-Gaiche, R. Kramer, Leticia Platero-Alonso, Rosa-María Álvarez-Gil, Olga-María Ces-Ozores, Victoria Nartallo-Penas
+12 more Susana Mirás-Carballal, Marta Piñeiro-Sotelo, Juan-Manuel González-Pérez, Carmen Rodríguez-Tenreiro-Sánchez, Ángela Manzanares-Casteleiro, Ana Dacosta-Urbieta, Cintia Álvarez-Smith, Irene Rivero-Calle, Antonio Salas, Carmen Durán-Parrondo, Narmeen Mallah, Federico Martinón-Torres
DOI: 10.1016/s1473-3099(25)00742-x
Cited by: 23
References: 30

Fields of Study & Subjects

Respiratory viral infections research Immunodeficiency and Autoimmune Disorders Pneumonia and Respiratory Infections

Publication details

Journal / source
The Lancet Infectious Diseases
Publisher
Elsevier BV
Volume
26
Issue
5
Pages
522–534
Publication date
13 January 2026
Language
EN